This inventor holds 1 USPTO granted patent. Top assignee: The Catholic University of Korea. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Eun-Ho Choo: Innovator in Myocardial Infarction Treatment
Introduction
Eun-Ho Choo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of myocardial infarction. His innovative work focuses on developing tolerogenic dendritic cells that can effectively address cardiac insufficiency following a heart attack.
Latest Patents
Eun-Ho Choo holds a patent for "Tolerogenic dendritic cells for treating myocardial infarction and manufacturing method thereof." This patent outlines a method for preparing tolerogenic dendritic cells that can treat cardiac insufficiency caused by excessive remodeling of the left ventricle during the recovery process after an acute myocardial infarction. The invention aims to inhibit inflammatory reactions and excessive remodeling, significantly reducing the incidence of cardiac insufficiency and providing an effective treatment for myocardial infarction.
Career Highlights
Eun-Ho Choo is affiliated with The Catholic University of Korea, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cardiac health and recovery.
Collaborations
Eun-Ho Choo has collaborated with notable colleagues, including Ki-Yuk Chang and Eun-Hye Park, to further enhance the research and development of his innovative treatments.
Conclusion
Eun-Ho Choo's contributions to the field of myocardial infarction treatment through his patented innovations highlight the importance of research in improving cardiac health. His work exemplifies the potential of medical advancements to significantly enhance patient outcomes.